Home > Press > Badwater Basin: Death Valley Microbe Thrives There: Discovery may lead to novel biotech and nanotech uses
Badwater Basin, lowest elevation in the Western Hemisphere, at Death Valley National Park.
Credit: Dennis Bazylinski and Christopher Lefèvre |
Abstract:
Nevada, the "Silver State," is well-known for mining precious metals.
But scientists Dennis Bazylinski and colleagues at the University of Nevada Las Vegas (UNLV) do a different type of mining.
They sluice through every water body they can find, looking for new forms of microbial magnetism.
In a basin named Badwater on the edge of Death Valley National Park, Bazylinski and researcher Christopher Lefèvre hit pay dirt.
Lefèvre is with the French National Center of Scientific Research and University of Aix-Marseille II.
In this week's issue of the journal Science, Bazylinski, Lefèvre and others report that they identified, isolated and grew a new type of magnetic bacteria that could lead to novel biotech and nanotech uses.
Magnetotactic bacteria are simple, single-celled organisms that are found in almost all bodies of water.
As their name suggests, they orient and navigate along magnetic fields like miniature swimming compass needles.
This is due to the nano-sized crystals of the minerals magnetite or greigite they produce.
The presence of these magnetic crystals makes the bacteria and their internal crystals--called magnetosomes--useful in drug delivery and medical imaging.
The research was funded by the U.S. National Science Foundation (NSF), the U.S. Department of Energy and the French Foundation for Medical Research.
"The finding is significant in showing that this bacterium has specific genes to synthesize magnetite and greigite, and that the proportion of these magnetosomes varies with the chemistry of the environment," said Enriqueta Barrera, program director in NSF's Division of Earth Sciences.
While many magnetite-producing bacteria can be grown and easily studied, Bazylinski and his team were the first to cultivate a greigite-producing species. Greigite is an iron sulfide mineral, the equivalent of the iron oxide magnetite.
"Because greigite-producing bacteria have never been isolated, the crystals haven't been tested for the types of biomedical and other applications that currently use magnetite," said Bazylinski.
"Greigite is an iron sulfide that may be superior to magnetite in some applications due to its slightly different physical and magnetic properties. Now we have the opportunity to find out."
Researchers found the greigite-producing bacterium, called BW-1, in water samples collected more than 280 feet below sea level in Badwater Basin. Lefèvre and Bazylinski later isolated and grew it leading to the discovery that BW-1 produces both greigite and magnetite.
A detailed look at its DNA revealed that BW-1 has two sets of magnetosome genes, unlike other such bacteria, which produce only one mineral and have only one set of magnetosome genes.
This suggests that the production of magnetite and greigite in BW-1 is likely controlled by separate sets of genes. That could be important in the mass production of either mineral for specific applications.
According to Bazylinski, the greigite-producing bacteria represent a new, previously unrecognized group of sulfate-reducing bacteria that "breathe" the compound sulfate rather than oxygen as most living organisms do.
"With how much is known about sulfate-reducing bacteria, it's surprising that no one has described this group," he said.
Working with Bazylinski and Lefèvre on the project are David Pignol of the French National Center of Scientific Research and University of Aix-Marseille II; Nicolas Menguy of Pierre and Marie Curie University, France; Fernanda Abreu and Ulysses Lins of the Federal University of Rio de Janeiro, Brazil; Mihaly Pósfai of the University of Pannonia, Hungary; Tanya Prozorov of Ames Laboratory, Iowa; and Richard Frankel of California Polytechnic State University, San Luis Obispo.
####
About National Science Foundation
The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2011, its budget is about $6.9 billion. NSF funds reach all 50 states through grants to nearly 2,000 universities and institutions. Each year, NSF receives over 45,000 competitive requests for funding, and makes over 11,500 new funding awards. NSF also awards over $400 million in professional and service contracts yearly.
For more information, please click here
Contacts:
Cheryl Dybas
NSF
(703) 292-7734
Shane Bevell
UNLV
(702) 895-2079
Copyright © National Science Foundation
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||